PharmacofMRI (Functional Magnetic Resonance Imaging) of Anxiolytic Medications (Alprazolam)

NCT00703885 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Anxiety Disorders

Interventions

DRUG: 0.25 mg alprazolam
DRUG: 1.0 mg alprazolam
DRUG: placebo

Sponsor

University of California, San Diego

Collaborators

[object Object]